Trials / Completed
CompletedNCT07015333
Case Review of Patients With Betel Nut-induced Oral Cancer Treated With Pembrolizumab and Cetuximab
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 31 (actual)
- Sponsor
- Commonwealth Healthcare Corporation · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Chart review of records of patients treated for betel nut-induced oral cancer with pembrolizumab and cetuximab.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pembrolizumab and cetuximab | Treatment of betel nut-induced oral cancer with pembrolizumab and cetuximab |
Timeline
- Start date
- 2020-03-01
- Primary completion
- 2024-11-01
- Completion
- 2024-12-01
- First posted
- 2025-06-11
- Last updated
- 2025-06-11
Locations
1 site across 1 country: Northern Mariana Islands
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07015333. Inclusion in this directory is not an endorsement.